Showing results (491-500 of 688) with videos related to

Sort By:
Pageof 69
Environmental Health Perspectives|August 10, 2007
The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitudeIngrid A F van der Mei, Anne-Louise Ponsonby, Ola Engelsen, et al.
Plants (Basel, Switzerland)|April 12, 2022
Characterisation of Grains and Flour Fractions from Field Grown Transgenic Oil-Accumulating Wheat Expressing Oat WRI1Per Snell, Mark Wilkinson, Gavin J Taylor, et al.
RMD Open|July 26, 2024
Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND studyRoy Fleischmann, Sebastian Meerwein, Christina Charles-Schoeman, et al.
International Journal of Rheumatic Diseases|May 17, 2023
Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trialsYoshiya Tanaka, Tsutomu Takeuchi, Derek Haaland, et al.
RMD Open|June 3, 2025
Benefit-risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular diseaseGerd R Burmester, Eduardo Mysler, Peter Taylor, et al.
Injury|July 13, 2018
High-energy trauma patients with pelvic fractures: Management trends in Ontario, CanadaStephen M Mann, Daniel Banaszek, Katherine Lajkosz, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|January 29, 2014
Multiple risk-behavior profiles of smokers with serious mental illness and motivation for changeJudith J Prochaska, Sebastien C Fromont, Kevin Delucchi, et al.
Arthritis Care & Research|October 4, 2016
Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled StudyArthur Kavanaugh, Philip J Mease, Andreas M Reimold, et al.
The Journal of Rheumatology|December 1, 2025
Validity and Psychometric Properties of 3 and 4 Visual Analog Scale in Participants With Psoriatic Arthritis Treated With GuselkumabWilliam Tillett, Laura C Coates, Marijn Vis, et al.
RMD Open|November 19, 2021
Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritisEffie Pournara, Matthias Kormaksson, Peter Nash, et al.
Pageof 69